JBS vs MDLZ
JBS N.v. and Mondelez International, Inc., side by side — 3 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | JBS | MDLZ |
|---|---|---|
| Revenue | $86.2B | $38.5B |
| Net income | $2.0B | $2.5B |
| Gross margin | 13.1% | 28.4% |
| Net margin | 2.6% | 6.4% |
| Return on equity | 25.6% | 9.3% |
| Diluted EPS | $1.89 | $1.89 |
| Dividend / share | · | $1.94 |
| Payout ratio | 77.7% | 101.5% |
| Free cash flow | $832.7M | $3.2B |
| Equity | $8.7B | $25.8B |
| Net debt / equity | −0.50× | 0.69× |
| Current ratio | 1.60× | 0.59× |
| Revenue CAGR 5y | · | 7.7% |
| Profit CAGR 5y | · | −7.2% |
JBS bills 2.2× the revenue of MDLZ, and MDLZ keeps more of each dollar of revenue as profit (6.4% against 2.6%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
3 years side by side
| Fiscal year | JBS | MDLZ |
|---|---|---|
| FY2025 | $86.2B | $38.5B |
| FY2024 | $77.2B | $36.4B |
| FY2023 | $72.9B | $36.0B |
Bottom line
| Fiscal year | JBS | MDLZ |
|---|---|---|
| FY2025 | $2.0B | $2.5B |
| FY2024 | $1.8B | $4.6B |
| FY2023 | $-198.9M | $5.0B |
Standard deviation, each side
MDLZ's net margin has been more volatile than JBS's over the 3 comparable fiscal years — 3.3 percentage points of standard deviation against 1.3.
3 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
MDLZ led in net margin in every one of the 3 comparable fiscal years — a structural lead, not a recent swing.
3 of 19 comparable fiscal years — a year missing data on either side is not counted.